#news #biotech MSKCC’s Maura Dickler to become Eli Lilly’s new late-stage cancer R&D lead

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: MSKCC’s Maura Dickler to become Eli Lilly’s new late-stage cancer R&D lead .Memorial Sloan Kettering Cancer Center’s Maura Dickler, M.D., has been lined up as Lilly’s new VP of late-phase development in oncology.

from FierceBiotech: Biotech http://ift.tt/2HjudUJ